Glial cells express nuclear NRF2 after fumarate treatment for multiple sclerosis and psoriasis

Neurology: Neuroimmunology and NeuroInflammation

Volumn 2, Issue 3, 2015, Pages e99-

  Metz, Imke ^a   Straßburger Krogias, Sarah Traffehn Katrin ^a,b   Keyvani, Kathy ^c   Bergmann, Markus ^d   Nolte, Kay ^e   Weber, Martin S ^a   Bartsch, Thorsten ^f   Gold, Ralf ^b   Brück, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d KLINIKUM BREMEN MITTE   (Germany)

^e RWTH AACHEN UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FUMADERM; FUMARIC ACID DIMETHYL ESTER; TRANSCRIPTION FACTOR NRF2;

ADULT; ARTICLE; BRAIN BIOPSY; CELL POPULATION; DISEASE SEVERITY; FEMALE; GLIA CELL; HEMIANOPIA; HUMAN; LYMPHOCYTE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSORIASIS; TREATMENT OUTCOME;

EID: 84933559802     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000099     Document Type: Article

References (6)

1. Linker RA, Lee DH, Ryan S, et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 2011;134:678-692.
2. Scannevin RH, Chollate S, Jung MY, et al. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J Pharmacol Exp Ther 2012;341:274-284.
3. van Horssen J, Witte ME, Schreibelt G, et al. Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta 2011;1812:141-150.
4. Kraft AD, Johnson DA, Johnson JA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 2004;24:1101-1112.
5. Chen PC, Vargas MR, Pani AK, et al. Nrf2-mediated neu-roprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc Natl Acad Sci USA 2009;106:2933-2938.
6. Salmen A, Gold R. Mode of action and clinical studies with fumarates in multiple sclerosis. Exp Neurol 2014; 262:52-56.